Aristotle Bamias

4.9k total citations · 1 hit paper
88 papers, 3.3k citations indexed

About

Aristotle Bamias is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Aristotle Bamias has authored 88 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Surgery, 31 papers in Pulmonary and Respiratory Medicine and 30 papers in Oncology. Recurrent topics in Aristotle Bamias's work include Bladder and Urothelial Cancer Treatments (29 papers), Urinary and Genital Oncology Studies (23 papers) and Renal cell carcinoma treatment (13 papers). Aristotle Bamias is often cited by papers focused on Bladder and Urothelial Cancer Treatments (29 papers), Urinary and Genital Oncology Studies (23 papers) and Renal cell carcinoma treatment (13 papers). Aristotle Bamias collaborates with scholars based in Greece, United States and Germany. Aristotle Bamias's co-authors include Meletios Α. Dimopoulos, Efstathios Kastritis, Evangelos Terpos, Dimitra Gika, Christina Bamia, Christos Papadimitriou, Ioannis Melakopoulos, George Bozas, Lia A. Moulopoulos and Vassiliki Koutsoukou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Aristotle Bamias

83 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors

2005 858 citations Aristotle Bamias, Efstathios Kastritis et al. profile →

Peers

Countries citing papers authored by Aristotle Bamias

Since Specialization

Citations

This map shows the geographic impact of Aristotle Bamias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aristotle Bamias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aristotle Bamias more than expected).

Fields of papers citing papers by Aristotle Bamias

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aristotle Bamias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aristotle Bamias. The network helps show where Aristotle Bamias may publish in the future.

Co-authorship network of co-authors of Aristotle Bamias

This figure shows the co-authorship network connecting the top 25 collaborators of Aristotle Bamias. A scholar is included among the top collaborators of Aristotle Bamias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aristotle Bamias. Aristotle Bamias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	3105P Sex-associated outcomes and Nectin-4 expression in Enfortumab Vedotin-treated advanced urothelial carcinoma 2025 ·Annals of Oncology ·Tarek Taha, Ash B. Alpert, (unknown), (unknown), (unknown), Federico Massari, Saurabh Gupta, (unknown), Aristotle Bamias, Sebastiano Buti, Hideki Takeshita, Ravindran Kanesvaran, Fernando Sabino Marques Monteiro, (unknown), (unknown)	0
2	Real-World Treatment Patterns in Patients With Metastatic Castration-Resistant Prostate Cancer in Greece: The PROSPECT Study 2024 ·Clinical Genitourinary Cancer ·Michalis Liontos, Evangelos Bournakis, (unknown), (unknown), Vassiliki Zolota, (unknown), Konstantinos Karalis, Anastasios Kyriazoglou, Roubini Zakopoulou, (unknown), Alexandros Tzovaras, Yannis Dimitriadis, (unknown), Davide Mauri, (unknown), Marinos Tsiatas, Flora Zagouri, Aristotle Bamias	0
3	RANGE: A randomized, double-blind, placebo-controlled phase 3 study of docetaxel (DOC) with or without ramucirumab (RAM) in platinum-refractory advanced or metastatic urothelial carcinoma 2017 ·Annals of Oncology ·Daniel P. Petrylak, K.N. Chi, Alexandra Drakaki, Cora N. Sternberg, Ronald de Wit, Hiroyuki Nishiyama, Edward Yu, Daniel Castellano, Syed A. Hussain, Ivor Percent, Aude Fléchon, Aristotle Bamias, Michiel S. van der Heijden, Nobuaki Matsubara, B. Yа. Alekseev, Richard A. Walgren, Omid Hamid, Annamaria H. Zimmermann, K.M. Bell-McGuinn, (unknown)	4
4	Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG) 2015 ·Clinical Genitourinary Cancer ·Aristotle Bamias, Stavros D. Peroukidis, (unknown), Kimon Tzannis, Konstantinos Koutsoukos, Charalambos Andreadis, V. Bozionelou, (unknown), Athanasios Papatsoris, Konstantinos Stravodimos, Ioannis Varthalitis, Michalis V. Karamouzis, Georgia Milaki, (unknown), (unknown), N. Androulakis, (unknown), Haralabos P. Kalofonos, Dimitriοs Mavroudis, Meletios Α. Dimopoulos	4
5	Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy 2013 ·Urologic Oncology Seminars and Original Investigations ·Matthew D. Galsky, Erin Moshier, (unknown), Chia‐Chi Lin, Noah M. Hahn, Thorsten Ecke, Guru Sonpavde, Gregory R. Pond, James Godbold, William Oh, Aristotle Bamias	9
6	ECHOCARDIOGRAPHY ASSESSMENT OF THE IMPACT OF BEVACIZUMAB ON SYSTOLIC AND DIASTOLIC FUNCTION OF LEFT VENTRICLE IN PATIENTS WITH METASTATIC CANCER 2012 ·Journal of the American College of Cardiology ·(unknown), Konstantinos Toutouzas, Andreas Synetos, Eleftherios Tsiamis, (unknown), Flora Zagouri, Aristotle Bamias, Meletios Α. Dimopoulos, (unknown), Dimitris Tousoulis, Christodoulos Stefanadis	0
7	Leukocytoclastic Vasculitis after Long-Term Treatment with Sunitinib: A Case Report 2011 ·SHILAP Revista de lepidopterología ·Alexandra Karadimou, (unknown), (unknown), Alexandros Stratigos, Christos Kittas, Meletios Α. Dimopoulos, Aristotle Bamias	6
8	A Risk-Adapted Strategy of Adjuvant Paclitaxel/Carboplatin in Early-Stage Ovarian Cancer: Time-Dependent Effect of 4 versus 6 Cycles on Outcome 2011 ·Oncology ·Aristotle Bamias, Christina Bamia, Alexandra Karadimou, (unknown), Flora Zagouri, Alexandros Rodolakis, Dimitrios Haidopoulos, George Vlahos, (unknown), A. Antsaklis, Meletios Α. Dimopoulos	0
9	Prostate Cancer with Metastasis to the Omentum and Massive Ascites: A Rare Manifestation of a Common Disease 2009 ·Onkologie ·(unknown), Maria Papaefthimiou, Athanasios N. Chalazonitis, Nikolaos Antoniou, Meletios Α. Dimopoulos, Aristotle Bamias	18
10	Targeting Angiogenesis in Renal Cell Carcinoma 2008 ·Current Cancer Drug Targets ·(unknown), Aristotle Bamias	51
11	Prognostic and Predictive Factors in Patients with Androgen-Independent Prostate Cancer Treated with Docetaxel and Estramustine: A Single Institution Experience 2007 ·European Urology ·Aristotle Bamias, George Bozas, Nikolaos Antoniou, (unknown), (unknown), Andreas Skolarikos, Dionysios Mitropoulos, Christos Alamanis, G. Alivizatos, (unknown), Meletios Α. Dimopoulos	18
12	Biweekly Carboplatin/Gemcitabine in Patients with Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: Report of Efficacy, Quality of Life and Geriatric Assessment 2007 ·Oncology ·Aristotle Bamias, (unknown), Efstathios Kastritis, (unknown), G. Alivizatos, Ανδρέας Κουρέας, Michael Chrisofos, Andreas Skolarikos, (unknown), Meletios Α. Dimopoulos	37
13	Intramedullary spinal cord and leptomeningeal metastases in a patient with carcinoma of the uterine cervix 2006 ·Gynecologic Oncology ·Efstathios Kastritis, Lia A. Moulopoulos, (unknown), Evangelos Kostis, (unknown), Meletios Α. Dimopoulos, Aristotle Bamias	14
14	Neoadjuvant chemotherapy in invasive bladder cancer 2005 ·Expert Review of Anticancer Therapy ·Aristotle Bamias, Meletios Α. Dimopoulos	2
15	Systemic chemotherapy in inoperable or metastatic bladder cancer 2005 ·Annals of Oncology ·Aristotle Bamias, (unknown), (unknown), Meletios Α. Dimopoulos	36
16	Thalidomide and immunomodulatory drugs in the treatment of cancer 2005 ·Expert Opinion on Investigational Drugs ·Aristotle Bamias, Meletios Α. Dimopoulos	17
17	Pulmonary toxicity from novel antineoplastic agents 2005 ·Annals of Oncology ·Ioanna Dimopoulou, Aristotle Bamias, Panagiotis Lyberopoulos, Meletios Α. Dimopoulos	97
18	Carboplatin Hypersensitivity Reactions: A Single Institution Experience 2005 ·Journal of Chemotherapy ·(unknown), (unknown), Eleni Galani, George Bozas, Efstathios Kastritis, Christos Papadimitriou, Meletios Α. Dimopoulos, Aristotle Bamias	10
19	DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder 2004 ·Urological Research ·C. Deliveliotis, (unknown), Andreas Skolarikos, (unknown), John Varkarakis, (unknown), (unknown), Aristotle Bamias	15
20	Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma 2003 ·Urology ·Aristotle Bamias, Maria Chorti, C. Deliveliotis, Νικόλαος Τράκας, Andreas Skolarikos, (unknown), (unknown), (unknown), (unknown), Meletios Α. Dimopoulos	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact